Ratings Creo Medical Group PLC

Equities

CREO

GB00BZ1BLL44

Market Closed - London S.E. 11:35:06 2024-04-26 am EDT 5-day change 1st Jan Change
36.25 GBX 0.00% Intraday chart for Creo Medical Group PLC +4.32% -21.20%

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • With an enterprise value anticipated at 3.26 times the sales for the current fiscal year, the company turns out to be overvalued.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
-21.20% 157M -
+73.17% 12.38B
B-
-18.74% 7.92B
C+
+16.15% 7.2B
C-
+4.81% 5.84B
B
+5.99% 5.01B
D+
+27.07% 4.53B -
-21.67% 3.88B
B-
-40.82% 2.23B
C
+1.49% 2.02B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CREO Stock
  4. Ratings Creo Medical Group PLC